TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Angarns Bio AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,481
|
3,091
|
2,655 |
| Financial expenses |
15
|
33
|
22 |
| Earnings before taxes |
1,709
|
2,793
|
2,428 |
| EBITDA |
1,754
|
2,899
|
2,538 |
| Total assets |
20,438
|
19,904
|
18,773 |
| Current assets |
2,452
|
2,612
|
1,247 |
| Current liabilities |
277
|
796
|
1,638 |
| Equity capital |
20,161
|
19,108
|
16,992 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.6%
|
96.0%
|
90.5% |
| Turnover per employee |
2,481
|
3,091
|
2,655 |
| Profit as a percentage of turnover |
68.9%
|
90.4%
|
91.5% |
| Return on assets (ROA) |
8.4%
|
14.2%
|
13.1% |
| Current ratio |
885.2%
|
328.1%
|
76.1% |
| Return on equity (ROE) |
8.5%
|
14.6%
|
14.3% |
| Change turnover |
-610
|
436
|
436 |
| Change turnover % |
-20%
|
16%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.